MeiraGTx Holdings plc (MGTX)
MeiraGTx Holdings plc (MGTX) from its SEC filings: 2025 revenue $81.4 million (+145% vs the year before), free cash flow -$50.2 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Biological Products, (No Diagnostic Substances) |
| Revenue (2025) | $81.4 million |
| Revenue growth | +145% |
| Free cash flow | -$50.2 million |
| Diluted EPS | $-1.42 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +8609% |
| Cash | $143.2 million |
| Share count, 1 year | +19% |
| Fundamentals check | Mixed fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.